QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL

<p>Aim. To study changes in quality of life (QoL) in patients with atrial fibrillation (AF) treated with warfarin after leaving the international clinical trial. Material and Methods. Patients with AF who were managed at cardiology department of the University Hospital participated in the stud...

Full description

Bibliographic Details
Main Authors: E. L. Artanova, L. E. Kon'shina, I. M. Sokolov, Y. G. Shvarts
Format: Article
Language:English
Published: Столичная издательская компания 2015-12-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:http://www.rpcardio.ru/jour/article/view/532
_version_ 1797762012197945344
author E. L. Artanova
L. E. Kon'shina
I. M. Sokolov
Y. G. Shvarts
author_facet E. L. Artanova
L. E. Kon'shina
I. M. Sokolov
Y. G. Shvarts
author_sort E. L. Artanova
collection DOAJ
description <p>Aim. To study changes in quality of life (QoL) in patients with atrial fibrillation (AF) treated with warfarin after leaving the international clinical trial. Material and Methods. Patients with AF who were managed at cardiology department of the University Hospital participated in the study. Patients of the main group (n=79) completed the international clinical trial with warfarin titration to therapeutic doses and subsequent therapy monitoring at least 1 year . Patients of the control group (n=23) had never taken part in clinical trials. QoL was evaluated with the 36-Item Short-Form Health Survey (SF 36) questionnaire after international clinical trial living or hospital discharge (initially) and in 3, 6 months of follow-up in outpatient clinic. Results. The most significant changes were observed in the first 3 months. In patients of the main group after clinical trial leaving physical component of QoL decreased from 65 (52.0-77.0) to 52 (25.0–55.0) points (p&lt;0.05) and emotional component – from 65 (55.0-70.0) to 60 (50.0–65.0) points (p&lt;0.05). At the same period opposite dynamics was observed in patients of the control group after hospital discharge. Physical component of QoL increased from 55 (25.0-65.0) to 65 (52.0–77.0) points (p&lt;0.05) and emotional component - from 60 (47.5- 65.0) to 70 (60.0–75.0) points (p&lt;0.05). In the next 3 months QoL levels have not changed significantly in patients of the both groups. Conclusion. International clinical trial living affects QoL in patients with AF . The physical component of QoL worsens most significantly.</p>
first_indexed 2024-03-12T19:21:17Z
format Article
id doaj.art-d5fb019558904aabbde41add8d40b64b
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-03-12T19:21:17Z
publishDate 2015-12-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-d5fb019558904aabbde41add8d40b64b2023-08-02T05:09:02ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-018215415710.1234/1819-6446-2012-2-154-157532QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIALE. L. Artanova0L. E. Kon'shina1I. M. Sokolov2Y. G. Shvarts3Саратовский государственный медицинский университет им. В.И. РазумовскогоСаратовский государственный медицинский университет им. В.И. РазумовскогоСаратовский государственный медицинский университет им. В.И. РазумовскогоСаратовский государственный медицинский университет им. В.И. Разумовского<p>Aim. To study changes in quality of life (QoL) in patients with atrial fibrillation (AF) treated with warfarin after leaving the international clinical trial. Material and Methods. Patients with AF who were managed at cardiology department of the University Hospital participated in the study. Patients of the main group (n=79) completed the international clinical trial with warfarin titration to therapeutic doses and subsequent therapy monitoring at least 1 year . Patients of the control group (n=23) had never taken part in clinical trials. QoL was evaluated with the 36-Item Short-Form Health Survey (SF 36) questionnaire after international clinical trial living or hospital discharge (initially) and in 3, 6 months of follow-up in outpatient clinic. Results. The most significant changes were observed in the first 3 months. In patients of the main group after clinical trial leaving physical component of QoL decreased from 65 (52.0-77.0) to 52 (25.0–55.0) points (p&lt;0.05) and emotional component – from 65 (55.0-70.0) to 60 (50.0–65.0) points (p&lt;0.05). At the same period opposite dynamics was observed in patients of the control group after hospital discharge. Physical component of QoL increased from 55 (25.0-65.0) to 65 (52.0–77.0) points (p&lt;0.05) and emotional component - from 60 (47.5- 65.0) to 70 (60.0–75.0) points (p&lt;0.05). In the next 3 months QoL levels have not changed significantly in patients of the both groups. Conclusion. International clinical trial living affects QoL in patients with AF . The physical component of QoL worsens most significantly.</p>http://www.rpcardio.ru/jour/article/view/532фибрилляция предсердийкачество жизниклинические исследованияварфарин
spellingShingle E. L. Artanova
L. E. Kon'shina
I. M. Sokolov
Y. G. Shvarts
QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL
Рациональная фармакотерапия в кардиологии
фибрилляция предсердий
качество жизни
клинические исследования
варфарин
title QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL
title_full QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL
title_fullStr QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL
title_full_unstemmed QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL
title_short QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL
title_sort quality of life and its dynamics in patients with atrial fibrillation after leaving the international clinical trial
topic фибрилляция предсердий
качество жизни
клинические исследования
варфарин
url http://www.rpcardio.ru/jour/article/view/532
work_keys_str_mv AT elartanova qualityoflifeanditsdynamicsinpatientswithatrialfibrillationafterleavingtheinternationalclinicaltrial
AT lekonshina qualityoflifeanditsdynamicsinpatientswithatrialfibrillationafterleavingtheinternationalclinicaltrial
AT imsokolov qualityoflifeanditsdynamicsinpatientswithatrialfibrillationafterleavingtheinternationalclinicaltrial
AT ygshvarts qualityoflifeanditsdynamicsinpatientswithatrialfibrillationafterleavingtheinternationalclinicaltrial